Stepan Reports Record Second Quarter Results and Record First Half Earnings
Second Quarter Highlights
- Reported net income was a record
$43.3 million , or$1.85 per diluted share, versus$35.7 million , or$1.54 per diluted share, in the prior year. Adjusted net income* was a second quarter record$42.2 million , or$1.81 per diluted share, versus$38.3 million , or$1.65 per diluted share, in the prior year.Total Company sales volume increased 5% versus the prior year. - Surfactant operating income was
$45.9 million versus$48.5 million in the prior year. This decrease was largely attributable to higher North American supply chain costs due to inflationary pressures and higher planned maintenance costs. Global Surfactant sales volume decreased 6% but the associated impact was more than offset by improved margins, product and customer mix. Consumer product sales volume was negatively impacted by feedstock supply issues following the first quarter 2021 severe weather inTexas , customer inventory rebalancing efforts and lower demand for cleaning products versus the pandemic peak in 2020. Higher demand for products sold into our institutional cleaning and functional product end markets partially offset the above.
- Polymer operating income was
$23.0 million versus$15.5 million in the prior year. This increase was primarily attributable to a 44% increase in global Polymer sales volume. Global rigid polyol volume was up 41% versus the prior year largely due to the INVISTA polyester polyol acquisition. Global rigid polyol volume, excluding the INVISTA acquisition, was up 7% versus the prior year. Higher demand within the phthalic anhydride and specialty polyols businesses also contributed to the sales volume growth. - Specialty Product operating income was
$7.0 million versus$3.2 million in the prior year. This increase was primarily attributable to order timing differences within our food and flavor business and improved margins within our medium chain triglycerides (MCT) product line. - The effect of foreign currency translation positively impacted net sales by 4% and net income by
$1.4 million , or$0.06 per diluted share, versus the prior year.
First Half Highlights
- Reported net income was a record
$83.9 million , or$3.59 per diluted share, versus$63.3 million , or$2.72 per diluted share, in the prior year. Adjusted net income* was a record$84.6 million , or$3.62 per diluted share, versus$62.5 million , or$2.69 per diluted share, in the prior year. The prior year first half results were negatively impacted by the first quarter 2020 Millsdale, IL plant power outage.Total Company sales volume was up 6% compared to the first six months of 2020. A 39% increase in global Polymer sales volume was partially offset by a 3% decrease in global Surfactant sales volume.
* |
Adjusted net income is a non-GAAP measure which excludes deferred compensation income/expense, cash-settled stock appreciation rights (SARs) income/expense, as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share. |
"The Company had a solid first half of 2021 and delivered record year-to-date results. Both adjusted net income and adjusted EPS were up 35% versus the first half of 2020 which was negatively impact by the Millsdale plant outage," said
Financial Summary
Three Months Ended |
Six Months Ended |
||||||||||||||||||||||
($ in thousands, except per share data) |
2021 |
2020 |
% Change |
2021 |
2020 |
% Change |
|||||||||||||||||
|
$ |
595,511 |
$ |
460,549 |
29 |
% |
$ |
1,133,251 |
$ |
910,536 |
24 |
% |
|||||||||||
Operating Income |
$ |
56,657 |
$ |
44,623 |
27 |
% |
$ |
110,571 |
$ |
84,627 |
31 |
% |
|||||||||||
Net Income Attributable to Stepan ** |
$ |
43,278 |
$ |
35,707 |
21 |
% |
$ |
83,889 |
$ |
63,252 |
33 |
% |
|||||||||||
Earnings per Diluted Share |
$ |
1.85 |
$ |
1.54 |
20 |
% |
$ |
3.59 |
$ |
2.72 |
32 |
% |
|||||||||||
Adjusted Net Income * |
$ |
42,218 |
$ |
38,315 |
10 |
% |
$ |
84,589 |
$ |
62,473 |
35 |
% |
|||||||||||
Adjusted Earnings per Diluted Share * |
$ |
1.81 |
$ |
1.65 |
10 |
% |
$ |
3.62 |
$ |
2.69 |
35 |
% |
* |
See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share. |
** |
Net Income Attributable to Stepan = Net Income – Net Income Attributable to Noncontrolling Interests |
Summary of Second Quarter Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense, cash-settled SARs income/expense and other significant and infrequent or non-recurring items.
- Deferred Compensation: The current year second quarter reported net income includes
$1.1 million of after-tax income versus$1.9 million of after-tax expense in the prior year. - Cash-Settled SARs: These management incentive instruments provide cash to participants equal to the appreciation on the price of specified shares of Company stock over a specified period of time. Because income or expense is recognized merely on the movement in the price of Company stock it has been excluded, similar to deferred compensation, to arrive at adjusted net income. The current year second quarter includes
$0.1 million of after-tax income versus$0.5 million of after-tax expense in the prior year. - Business Restructuring: The current year second quarter includes
$0.1 million of after-tax decommissioning expense related to the Company's Canadian plant closure versus$0.2 million of after-tax expense in the prior year.
Percentage Change in
Net sales in the second quarter of 2021 increased 29% year-over-year due to higher selling prices, mainly due to improved product and customer mix and the pass-through of higher raw material costs, a 5% increase in global sales volume and the favorable impact of foreign currency translation. The increase in sales volume was predominantly due to Polymer sales growth of 44%.
Three Months Ended |
Six Months Ended |
|||||||
Volume |
5 |
% |
6 |
% |
||||
Selling Price & Mix |
20 |
% |
16 |
% |
||||
Foreign Translation |
4 |
% |
2 |
% |
||||
Total |
29 |
% |
24 |
% |
Segment Results |
||||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2021 |
2020 |
% Change |
2021 |
2020 |
% Change |
||||||||||||||||||
|
||||||||||||||||||||||||
Surfactants |
$ |
384,002 |
$ |
332,335 |
16 |
% |
$ |
754,938 |
$ |
659,406 |
14 |
% |
||||||||||||
Polymers |
$ |
190,538 |
$ |
112,409 |
70 |
% |
$ |
340,923 |
$ |
218,900 |
56 |
% |
||||||||||||
Specialty Products |
$ |
20,971 |
$ |
15,805 |
33 |
% |
$ |
37,390 |
$ |
32,230 |
16 |
% |
||||||||||||
Total |
$ |
595,511 |
$ |
460,549 |
29 |
% |
$ |
1,133,251 |
$ |
910,536 |
24 |
% |
||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2021 |
2020 |
% Change |
2021 |
2020 |
% Change |
||||||||||||||||||
Operating Income |
||||||||||||||||||||||||
Surfactants |
$ |
45,896 |
$ |
48,503 |
(5) |
% |
$ |
99,106 |
$ |
84,659 |
17 |
% |
||||||||||||
Polymers |
$ |
23,025 |
$ |
15,527 |
48 |
% |
$ |
40,976 |
$ |
23,043 |
78 |
% |
||||||||||||
Specialty Products |
$ |
6,977 |
$ |
3,226 |
116 |
% |
$ |
9,610 |
$ |
7,210 |
33 |
% |
||||||||||||
Total Segment Operating Income |
$ |
75,898 |
$ |
67,256 |
13 |
% |
$ |
149,692 |
$ |
114,912 |
30 |
% |
||||||||||||
Corporate Expenses |
$ |
(19,241) |
$ |
(22,633) |
(15) |
% |
$ |
(39,121) |
$ |
(30,285) |
29 |
% |
||||||||||||
Consolidated Operating Income |
$ |
56,657 |
$ |
44,623 |
27 |
% |
$ |
110,571 |
$ |
84,627 |
31 |
% |
Total segment operating income increased
- Surfactant net sales were
$384.0 million for the quarter, a 16% increase versus the prior year. Selling prices were up 17% primarily due to improved product and customer mix as well as the pass-through of higher raw material costs. The effect of foreign currency translation positively impacted net sales by 5%. Sales volume in the second quarter of 2021 decreased 6% year-over-year. Most of this decrease reflects lower sales volume into the North American consumer product end markets as a result of feedstock supply issues, customer inventory rebalancing efforts and lower demand for consumer cleaning, disinfection and personal wash products versus the pandemic peak in 2020. Higher demand for products sold into our institutional cleaning and functional product end markets partially offset the above. Surfactant operating income for the quarter decreased$2.6 million , or 5%, versus the prior year quarter primarily due higher North American supply chain costs related to inflationary pressures and planned higher maintenance costs. Improved margins, product and customer mix partially offset the impact of the 6% decline in global sales volume and higher supply chain costs. Latin American operating results benefited from a$2.1 million VAT tax recovery in the current year quarter. - Polymer net sales were
$190.5 million for the quarter, a 70% increase versus the prior year. Sales volume increased 44% in the quarter primarily due to 41% growth in rigid polyol demand. Global rigid polyol volume, excluding the INVISTA acquisition, was up 7% versus the prior year. Higher demand within the phthalic anhydride and specialty polyols businesses also contributed to the sales volume growth. Selling prices increased 21% and the translation impact of a weakerU.S. dollar positively increased net sales by 5%. Polymer operating income increased$7.5 million , or 48%, primarily due to the strong sales volume growth.
- Specialty Product net sales were
$21.0 million for the quarter, up 33% versus the prior year. Sales volume was up 17% between quarters and operating income increased$3.8 million , or 116%. The operating income increase was primarily attributable to order timing differences within our food and flavor business and improved margins within our medium chain triglycerides product line.
Corporate Expenses |
||||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2021 |
2020 |
% Change |
2021 |
2020 |
% Change |
||||||||||||||||||
Total Corporate Expenses |
$ |
19,241 |
$ |
22,633 |
(15) |
% |
$ |
39,121 |
$ |
30,285 |
29 |
% |
||||||||||||
Less: |
||||||||||||||||||||||||
Deferred Compensation |
$ |
(958) |
$ |
(6,464) |
(85) |
% |
$ |
(3,652) |
$ |
859 |
NM |
|||||||||||||
Business Restructuring |
$ |
(114) |
$ |
(225) |
(49) |
% |
$ |
(195) |
$ |
(582) |
(66) |
% |
||||||||||||
Adjusted Corporate Expense |
$ |
18,169 |
$ |
15,944 |
14 |
% |
$ |
35,274 |
$ |
30,562 |
15 |
% |
* See Table III for a discussion of deferred compensation plan accounting. |
- Corporate expenses, excluding deferred compensation and business restructuring costs, increased
$2.2 million , or 14%, versus the prior year quarter. The quarterly increase was primarily due to the non-recurrence of a sales and use tax refund received in the second quarter of 2020 combined with higher acquisition-related expenses, insurance premiums and cloud application costs in 2021.
Income Taxes
The Company's effective tax rate was 24.4% for the first half of 2021 versus 23.9% for the first half of 2020. This year-over-year increase was primarily attributable to a less favorable geographical mix of income in the first half of 2021 versus 2020, partially offset by higher tax benefits derived from stock-based compensation awards exercised or distributed in the first half of 2021 versus 2020.
Shareholder Return
The Company paid
Selected Balance Sheet Information
The Company's net debt level increased
($ in millions) |
|
|
|
||||||||
Net Debt |
|||||||||||
Total Debt |
$ |
238.9 |
$ |
248.4 |
$ |
198.7 |
|||||
Cash |
127.1 |
150.7 |
349.9 |
||||||||
Net Debt |
$ |
111.8 |
$ |
97.7 |
$ |
(151.2) |
|||||
Equity |
1,048.8 |
1,002.3 |
986.7 |
||||||||
Net Debt + Equity |
$ |
1,160.6 |
$ |
1,100.0 |
$ |
835.5 |
|||||
Net Debt / (Net Debt + Equity) |
10 |
% |
9 |
% |
-18 |
% |
The major working capital components were:
($ in millions) |
|
|
|
||||||||
Net Receivables |
$ |
391.7 |
$ |
380.6 |
$ |
301.3 |
|||||
Inventories |
266.1 |
235.1 |
218.8 |
||||||||
Accounts Payable |
(286.9) |
(264.2) |
(236.8) |
||||||||
Total |
$ |
370.9 |
$ |
351.5 |
$ |
283.3 |
Capital spending was
Outlook
"The Company delivered record earnings in the first half of 2021," said
Conference Call
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.
Corporate Profile
Headquartered in
The Company's common stock is traded on the
More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com.
Contact:
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about
There are a number of risks, uncertainties and other important factors, many of which are beyond
These forward-looking statements are made only as of the date hereof, and
Table I |
||||||||||||||||
|
||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
|
$ |
595,511 |
$ |
460,549 |
$ |
1,133,251 |
$ |
910,536 |
||||||||
Cost of Sales |
483,830 |
362,054 |
912,590 |
732,772 |
||||||||||||
Gross Profit |
111,681 |
98,495 |
220,661 |
177,764 |
||||||||||||
Operating Expenses: |
||||||||||||||||
Selling |
14,990 |
12,921 |
29,494 |
26,453 |
||||||||||||
Administrative |
23,974 |
20,731 |
46,612 |
39,603 |
||||||||||||
Research, Development and Technical Services |
14,988 |
13,531 |
30,137 |
27,358 |
||||||||||||
Deferred Compensation (Income) Expense |
958 |
6,464 |
3,652 |
(859) |
||||||||||||
54,910 |
53,647 |
109,895 |
92,555 |
|||||||||||||
Business Restructuring |
114 |
225 |
195 |
582 |
||||||||||||
Operating Income |
56,657 |
44,623 |
110,571 |
84,627 |
||||||||||||
Other Income (Expense): |
||||||||||||||||
Interest, Net |
(1,567) |
(1,259) |
(3,091) |
(2,489) |
||||||||||||
Other, Net |
2,758 |
4,437 |
3,504 |
1,175 |
||||||||||||
1,191 |
3,178 |
413 |
(1,314) |
|||||||||||||
Income Before Income Taxes |
57,848 |
47,801 |
110,984 |
83,313 |
||||||||||||
Provision for Income Taxes |
14,545 |
11,958 |
27,070 |
19,931 |
||||||||||||
Net Income |
43,303 |
35,843 |
83,914 |
63,382 |
||||||||||||
Net Income Attributable to Noncontrolling Interests |
(25) |
(136) |
(25) |
(130) |
||||||||||||
Net Income Attributable to |
$ |
43,278 |
$ |
35,707 |
$ |
83,889 |
$ |
63,252 |
||||||||
Net Income Per Common Share Attributable to |
||||||||||||||||
Basic |
$ |
1.89 |
$ |
1.56 |
$ |
3.65 |
$ |
2.75 |
||||||||
Diluted |
$ |
1.85 |
$ |
1.54 |
$ |
3.59 |
$ |
2.72 |
||||||||
Shares Used to Compute Net Income Per Common Share Attributable to |
||||||||||||||||
Basic |
22,952 |
22,923 |
22,963 |
22,973 |
||||||||||||
Diluted |
23,345 |
23,184 |
23,338 |
23,235 |
||||||||||||
Table II |
||||||||||||||||||||||||||||||||
Reconciliations of Non-GAAP Net Income and Earnings per Diluted Share * |
||||||||||||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
2021 |
EPS |
2020 |
EPS |
2021 |
EPS |
2020 |
EPS |
||||||||||||||||||||||||
Net Income Reported |
$ |
43,278 |
$ |
1.85 |
$ |
35,707 |
$ |
1.54 |
$ |
83,889 |
$ |
3.59 |
$ |
63,252 |
$ |
2.72 |
||||||||||||||||
Deferred Compensation (Income) Expense |
$ |
(1,050) |
$ |
(0.04) |
$ |
1,938 |
$ |
0.08 |
$ |
451 |
$ |
0.02 |
$ |
(920) |
$ |
(0.04) |
||||||||||||||||
Business Restructuring Expense |
$ |
85 |
$ |
0.00 |
$ |
168 |
$ |
0.01 |
$ |
146 |
$ |
0.01 |
$ |
431 |
$ |
0.02 |
||||||||||||||||
Cash-Settled SARs (Income) Expense |
$ |
(95) |
$ |
(0.00) |
$ |
502 |
$ |
0.02 |
$ |
103 |
$ |
0.00 |
$ |
(290) |
$ |
(0.01) |
||||||||||||||||
Adjusted Net Income |
$ |
42,218 |
$ |
1.81 |
$ |
38,315 |
$ |
1.65 |
$ |
84,589 |
$ |
3.62 |
$ |
62,473 |
$ |
2.69 |
* |
All amounts in this table are presented after-tax |
The Company believes that certain measures that are not in accordance with generally accepted accounting principles (GAAP), when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and provide better clarity on the impact of non-operational items. Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators. These measures should be considered in addition to, and neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP.
Reconciliation of Pre-Tax to After-Tax Adjustments |
||||||||||||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
2021 |
EPS |
2020 |
EPS |
2021 |
EPS |
2020 |
EPS |
||||||||||||||||||||||||
Pre-Tax Adjustments |
||||||||||||||||||||||||||||||||
Deferred Compensation (Income) Expense |
$ |
(1,381) |
$ |
2,550 |
$ |
594 |
$ |
(1,210) |
||||||||||||||||||||||||
Business Restructuring Expense |
$ |
114 |
$ |
225 |
$ |
195 |
$ |
582 |
||||||||||||||||||||||||
Cash-Settled SARs (Income) Expense |
$ |
(125) |
$ |
661 |
$ |
136 |
$ |
(381) |
||||||||||||||||||||||||
Total Pre-Tax Adjustments |
$ |
(1,392) |
$ |
3,436 |
$ |
925 |
$ |
(1,009) |
||||||||||||||||||||||||
Cumulative Tax Effect on Adjustments |
$ |
332 |
$ |
(828) |
$ |
(225) |
$ |
230 |
||||||||||||||||||||||||
After-Tax Adjustments |
$ |
(1,060) |
$ |
(0.04) |
$ |
2,608 |
$ |
0.11 |
$ |
700 |
$ |
0.03 |
$ |
(779) |
$ |
(0.03) |
Table III |
||||||||||||||||||||||||||||
Deferred Compensation Plans |
||||||||||||||||||||||||||||
The full effect of deferred compensation plans on quarterly pre-tax income was |
||||||||||||||||||||||||||||
2021 |
2020 |
|||||||||||||||||||||||||||
12/31 |
9/30 |
6/30 |
3/31 |
12/31 |
9/30 |
6/30 |
3/31 |
|||||||||||||||||||||
|
N/A |
N/A |
$ |
120.27 |
$ |
127.11 |
$ |
119.32 |
$ |
109.00 |
$ |
97.10 |
$ |
88.46 |
||||||||||||||
The deferred compensation income statement impact is summarized below: |
||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
($ in thousands) |
2021 |
2020 |
2021 |
2020 |
||||||||||||
Deferred Compensation |
||||||||||||||||
Operating Income (Expense) |
$ |
(958) |
$ |
(6,464) |
$ |
(3,652) |
$ |
859 |
||||||||
Other, net – Mutual Fund Gain |
2,339 |
3,914 |
3,058 |
351 |
||||||||||||
Total Pretax |
$ |
1,381 |
$ |
(2,550) |
$ |
(594) |
$ |
1,210 |
||||||||
Total After Tax |
$ |
1,050 |
$ |
(1,938) |
$ |
(451) |
$ |
920 |
Table IV |
||||||||||||||||||||||||||||||||
Effects of Foreign Currency Translation |
||||||||||||||||||||||||||||||||
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into |
||||||||||||||||||||||||||||||||
($ in millions) |
Three Months Ended |
Increase |
Increase Due to Foreign Currency Translation |
Six Months Ended |
Increase |
Increase Due to Foreign Currency Translation |
||||||||||||||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||||||||||||||||||
|
$ |
595.5 |
$ |
460.5 |
$ |
135.0 |
$ |
20.3 |
$ |
1,133.3 |
$ |
910.5 |
$ |
222.8 |
$ |
24.6 |
||||||||||||||||
Gross Profit |
111.7 |
98.5 |
13.2 |
2.7 |
220.7 |
177.8 |
42.9 |
2.9 |
||||||||||||||||||||||||
Operating Income |
56.7 |
44.6 |
12.1 |
1.7 |
110.6 |
84.6 |
26.0 |
1.6 |
||||||||||||||||||||||||
Pretax Income |
57.8 |
47.8 |
10.0 |
1.9 |
111.0 |
83.3 |
27.7 |
2.0 |
Table V |
||||||||
|
||||||||
|
|
|||||||
ASSETS |
||||||||
Current Assets |
$ |
815,855 |
$ |
905,651 |
||||
Property, Plant & Equipment, Net |
764,784 |
682,667 |
||||||
Other Assets |
306,666 |
164,018 |
||||||
Total Assets |
$ |
1,887,305 |
$ |
1,752,336 |
||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||
Current Liabilities |
$ |
464,501 |
$ |
416,554 |
||||
Deferred Income Taxes |
9,995 |
20,745 |
||||||
Long-term Debt |
196,529 |
160,812 |
||||||
Other Non-current Liabilities |
165,764 |
165,860 |
||||||
Total Stepan Company Stockholders' Equity |
1,048,801 |
986,693 |
||||||
Noncontrolling Interest |
1,715 |
1,672 |
||||||
Total Liabilities and Stockholders' Equity |
$ |
1,887,305 |
$ |
1,752,336 |
View original content:https://www.prnewswire.com/news-releases/stepan-reports-record-second-quarter-results-and-record-first-half-earnings-301342926.html
SOURCE